Loading…
DataMeds AI, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in MEDS.
▼ -97.7% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MTNBMatinas BioPharma Holdings, Inc. | $0.20 | — | 0.7x | — | -141.24% | $2.94M |
| PRFXPRF Technologies Ltd. | $0.96 | — | 0.1x | — | -90.37% | $2.92M |
| BIAFbioAffinity Technologies, Inc. | $4.87 | — | 0.6x | — | -1860.15% | $2.88M |
| GNPXGenprex, Inc. | $3.67 |
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Company description provided by Yahoo Finance.
| 0.1x |
| 0.1x |
| — |
| -203.86% |
| $3.01M |
| NUWENuwellis, Inc. | $0.89 | 0.0x | — | — | — | $2.82M |
| PPCBPropanc Biopharma, Inc. | $1.35 | 0.0x | 0.1x | — | -126.98% | $3.08M |